At meeting held on 01 November 2022
The Board of Sun Pharmaceuticals Industries at its meeting held on 01 November 2022 has approved the appointment of Sanjay Asher (DIN: 00008221), as an Additional Director designated as an Independent Director of the Company for a term commencing from 01 November 2022 till 31 March 2025, subject to approval of the shareholders.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
